Cart

Home>Dictionaries>Dictionary of Pharmaceutical Industry und Research – 2 User License

Dictionary of Pharmaceutical Industry und Research – 2 User License

Back to search

Dictionary of Pharmaceutical Industry und Research - 2 User License quantity

Description

Contact

Wallensteinstr. 61-63
D - 90431 Nürnberg

Tel.: +49 - (0)911 / 37 66 75 - 0
Fax: +49 - (0)911 / 37 66 75 - 29

info@acolada.de

* Price including statutory VAT.
A one-time fee is added for the first online dictionary in the net amount of 24,00 EUR.

Acolada GmbH

Welcome to Acolada. Since 2001 we have been successfully supporting our customers in managing and publishing their valuable content.

With Sirius CMS, the highly flexible XML and SGML authoring system, we provide a first-class environment for the creation, management and publication of data in the fields of documentation, training documents, parts catalogues and publishing content.

The Word-like XML editing software SIMQIN enables valid XML data to be created and managed in a pleasant author interface.

The Cobrili content delivery platform is a modern online and offline platform for your help systems and training documents.

The UniLex product series for electronic dictionaries and terminology has been growing constantly for more than 20 years, taking into account the requirements of language experts for intelligent search methods.

The UniTerm product range provides professional terminology management that meets all demands.

The Velingua modules available help you to develop your terminology, check whether this is being used correctly and provide linguistic knowledge.

We will happily advise you on how our technology can be specifically used for your tasks.

Acolada GmbH

Additional hints

EU regulation on online dispute resolution in consumer affairs
The European Commission provides a platform for extrajudicial online dispute resolution at http://ec.europa.eu/consumers/odr/.

Our e-mail for consumer complaints is: info@acolada.de

Imprint
Support
Data protection
Right to object
Contacting Acolada
News